PHAT•benzinga•
HC Wainwright & Co. Maintains Buy on Phathom Pharmaceuticals, Lowers Price Target to $20
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2025 by benzinga